Biomarker identification in astrocytoma, IDH-mutant CNS WHO grade 3-A Transcriptome profiling based approach
Retrospective clinical analysis and pathological significance of biomarkers for astrocytoma progression
Activation of Wnt/β-catenin/Tcf signaling pathway in gliomas: a potential target for nonsteroidal anti-inflammatory drugs celecoxib and diclofenac
